临床试验正在测试一种新的装置,以减少慢性心血管炎不适应标准治疗的成年人的胸痛。 A clinical trial is testing a new device to reduce chest pain in adults with chronic angina unresponsive to standard treatment.

名为COSIRA II的临床试验正在将患有慢性心血管炎的成年人招入,尽管最大程度的药物治疗是为了测试一个旨在减少胸痛和改善症状的调查装置。 A clinical trial called COSIRA II is enrolling adults with ongoing chronic angina despite maximum medication therapy to test an investigational device aimed at reducing chest pain and improving symptoms. 大约1 100万美国人有心肌梗塞,原因往往是心脏血液流量减少,多达40%的人在接受标准治疗后仍然有症状。 About 11 million Americans have angina, often due to reduced heart blood flow, and up to 40% still experience symptoms after standard treatments. 该研究试图评价该装置的安全性和有效性,为有持久性症状的病人提供潜在的新选择。 The study seeks to evaluate the device’s safety and effectiveness, offering potential new options for patients with persistent symptoms. 可通过特定地点参与,可通过震波医疗公司提供更多详情。 Participation is available through specific sites, and more details are available via Shockwave Medical. 该设备仅用于研究用途。 The device is for research use only.